Literature DB >> 15569733

Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE.

Carles Majós1, Margarida Julià-Sapé, Juli Alonso, Marta Serrallonga, Carles Aguilera, Juan J Acebes, Carles Arús, Jaume Gili.   

Abstract

BACKGROUND AND
PURPOSE: Different TE can be used for obtaining MR spectra of brain tumors. The purpose of this study was to determine the influence of the TE used in brain tumor classification by comparing the performance of spectra obtained at two different TE (30 ms and 136 ms).
METHODS: One hundred fifty-one studies of patients with brain tumors (37 meningiomas, 12 low grade astrocytomas, 16 anaplastic astrocytomas, 54 glioblastomas, and 32 metastases) were retrospectively selected from a series of 378 consecutive examinations of brain masses. Single voxel proton MR spectroscopy at TE 30 ms and 136 ms was performed with point-resolved spectroscopy in all cases. Fitted areas of nine resonances of interest were normalized to water. Tumors were classified into four groups (meningioma, low grade astrocytoma, anaplastic astrocytoma, and glioblastoma-metastases) by means of linear discriminant analysis. The performance of linear discriminant analysis at each TE was assessed by using the leave-one-out method.
RESULTS: Tumor classification was slightly better at short TE (123 [81%] of 151 cases correctly classified) than at long TE (118 [78%] of 151 cases correctly classified). Meningioma was the only group that showed higher sensitivity and specificity at long TE. Improved results were obtained when both TE were considered simultaneously: the suggested diagnosis was correct in 105 (94%) of 112 cases when both TE agreed, whereas the correct diagnosis was suggested by at least one TE in 136 (90%) of 151 cases.
CONCLUSION: Short TE provides slightly better tumor classification, and results improve when both TE are considered simultaneously. Meningioma was the only tumor group in which long TE performed better than short TE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569733      PMCID: PMC8148728     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Coupling effects in volume selective 1H spectroscopy of major brain metabolites.

Authors:  T Ernst; J Hennig
Journal:  Magn Reson Med       Date:  1991-09       Impact factor: 4.668

Review 2.  Clinical applications of proton MR spectroscopy.

Authors:  M Castillo; L Kwock; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  1996-01       Impact factor: 3.825

3.  Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.

Authors:  Carles Majós; Juli Alonso; Carles Aguilera; Marta Serrallonga; Juan J Acebes; Carles Arús; Jaume Gili
Journal:  Radiology       Date:  2002-11       Impact factor: 11.105

4.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings.

Authors:  I M Burtscher; G Skagerberg; B Geijer; E Englund; F Ståhlberg; S Holtås
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

5.  Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas.

Authors:  I Barba; A Moreno; I Martinez-Pérez; A R Tate; M E Cabañas; M Baquero; A Capdevila; C Arús
Journal:  J Neurosurg       Date:  2001-01       Impact factor: 5.115

6.  Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.

Authors:  H Ishimaru; M Morikawa; S Iwanaga; M Kaminogo; M Ochi; K Hayashi
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 7.  From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods.

Authors:  G Hagberg
Journal:  NMR Biomed       Date:  1998 Jun-Aug       Impact factor: 4.044

Review 8.  Towards a method for automated classification of 1H MRS spectra from brain tumours.

Authors:  A R Tate; J R Griffiths; I Martínez-Pérez; A Moreno; I Barba; M E Cabañas; D Watson; J Alonso; F Bartumeus; F Isamat; I Ferrer; F Vila; E Ferrer; A Capdevila; C Arús
Journal:  NMR Biomed       Date:  1998 Jun-Aug       Impact factor: 4.044

9.  Focal brain lesions: effect of single-voxel proton MR spectroscopic findings on treatment decisions.

Authors:  A J Adamson; S D Rand; R W Prost; T A Kim; C Schultz; V M Haughton
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

10.  Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study.

Authors:  A Rosemary Tate; Carles Majós; Angel Moreno; Franklyn A Howe; John R Griffiths; Carles Arús
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

View more
  47 in total

1.  New similarity search based glioma grading.

Authors:  Katrin Haegler; Martin Wiesmann; Christian Böhm; Jessica Freiherr; Oliver Schnell; Hartmut Brückmann; Jörg-Christian Tonn; Jennifer Linn
Journal:  Neuroradiology       Date:  2011-12-14       Impact factor: 2.804

2.  Investigating machine learning techniques for MRI-based classification of brain neoplasms.

Authors:  Evangelia I Zacharaki; Vasileios G Kanas; Christos Davatzikos
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-04-23       Impact factor: 2.924

3.  Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.

Authors:  Irene Neuner; Joachim B Kaffanke; Karl-Josef Langen; Elena Rota Kops; Lutz Tellmann; Gabriele Stoffels; Christoph Weirich; Christian Filss; Jürgen Scheins; Hans Herzog; N Jon Shah
Journal:  Eur Radiol       Date:  2012-07-11       Impact factor: 5.315

Review 4.  Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Authors:  Michelle M Kim; Abhijit Parolia; Mark P Dunphy; Sriram Venneti
Journal:  Nat Rev Clin Oncol       Date:  2016-07-19       Impact factor: 66.675

Review 5.  Neuroradiology of childhood brain tumors: new challenges.

Authors:  Louis-Gilbert Vézina
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

Review 6.  A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.

Authors:  W Hollingworth; L S Medina; R E Lenkinski; D K Shibata; B Bernal; D Zurakowski; B Comstock; J G Jarvik
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

Review 7.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

8.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.

Authors:  Marc Kalis; Brian C Bowen; Robert M Quencer
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

9.  HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI.

Authors:  Marina Radoul; Chloé Najac; Pavithra Viswanath; Joydeep Mukherjee; Mark Kelly; Anne Marie Gillespie; Myriam M Chaumeil; Pia Eriksson; Romelyn Delos Santos; Russell O Pieper; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2018-12-18       Impact factor: 4.044

10.  Magnetic resonance spectroscopy in posterior fossa tumours: the tumour spectroscopic signature may improve discrimination in adults among haemangioblastoma, ependymal tumours, medulloblastoma, and metastasis.

Authors:  Paloma Mora; Albert Pons; Mónica Cos; Angels Camins; Amadeo Muntané; Carles Aguilera; Carles Arús; Carles Majós
Journal:  Eur Radiol       Date:  2018-12-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.